If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad. In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development. Opportunities are listed according chronological order, the most recent first.

Seeking: Ibuprofen Fixed Dose Combinations

Popular

Description

apple_star.jpgOur client is a major global pharmaceutical company with very successful well-known consumer brands and is interested in licensing OTC formulations of Ibuprofen and Caffeine fixed-dose-combination (FDC) for migraine and/or headache treatment.

More specifically the licensor is looking for:

1. Ibuprofen-Caffeine FDC dossier for the European markets
2. Ibuprofen-Acetaminophen-Caffeine dossier FDC for the Canadian market

Requirements:
• Strong clinical and scientific data for treatment of for migraine and/or headache. And although, clinical studies are preferable, PK data will be considered.
• The licensor prefers an exclusive right for the formula/dossier. However non-exclusive right may be considered
• The licensor prefers to manufacture the product at own facilitates, however may consider supply arrangement
• The licensor will market the product under own brand in both Europe and Canada.
• A complete dossier with marketing authorization is preferable but pipeline opportunities will be considered.
• The licensor is open to discuss various business models

Please send your proposals to info@farmavita.net 

More details

Name Description
Pharma licensing In-licensing (demand)

Ad details

Ad ID : 794

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
763 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
629 Views
Profitable and Modern Russian CMO with long...
595 Views
Adalimumab API available: - from EU cGMP...
10338 Views
Infliximab API available: - from EU cGMP...
603 Views
Normal 0 false false false EN-US X-NONE HE /*...
588 Views
Start-up pharmaceutical company from South...
2038 Views